Your browser doesn't support javascript.
loading
The IPTA Nashville consensus conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: II-consensus guidelines for prevention.
Green, Michael; Squires, James E; Chinnock, Richard E; Comoli, Patrizia; Danziger-Isakov, Lara; Dulek, Daniel E; Esquivel, Carlos O; Höcker, Britta; L'Huillier, Arnaud G; Mazariegos, George Vincent; Visner, Gary A; Bollard, Catherine M; Dipchand, Anne I; Ferry, Judith A; Gross, Thomas G; Hayashi, Robert; Maecker-Kolhoff, Britta; Marks, Stephen; Martinez, Olivia M; Metes, Diana M; Michaels, Marian G; Preiksaitis, Jutta; Smets, Françoise; Swerdlow, Stephen H; Trappe, Ralf U; Wilkinson, James D; Allen, Upton; Webber, Steven A; Dharnidharka, Vikas R.
Afiliação
  • Green M; Division of Pediatric Infectious Diseases, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Squires JE; Division of Gastroenterology, Hepatology and Nutrition, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Chinnock RE; Loma Linda University Children's Hospital, California, USA.
  • Comoli P; Cell Factory & Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico, San Matteo, Pavia, Italy.
  • Danziger-Isakov L; Division of Infectious Disease, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.
  • Dulek DE; Division of Pediatric Infectious Diseases, Monroe Carell Jr. Children's Hospital at Vanderbilt and Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Esquivel CO; Stanford University School of Medicine, Stanford, California, USA.
  • Höcker B; Pediatrics I, University Children's Hospital, Heidelberg, Germany.
  • L'Huillier AG; Pediatric Infectious Diseases Unit and Laboratory of Virology, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Mazariegos GV; Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh and Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Visner GA; Division of Pulmonary Medicine, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts, USA.
  • Bollard CM; Center for Cancer and Immunology Research, Children's National Hospital, The George Washington University, Washington, District of Columbia, USA.
  • Dipchand AI; Labatt Family Heart Centre, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Ferry JA; Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Gross TG; Center for Cancer and Blood Diseases, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Hayashi R; Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri, USA.
  • Maecker-Kolhoff B; Hannover Medical School, Pediatric Hematology and Oncology, Hannover, Germany.
  • Marks S; Department of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Martinez OM; NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, Great Ormond Street Institute of Child Health, London, UK.
  • Metes DM; Department of Surgery and Program in Immunology, Stanford University School of Medicine, Stanford, California, USA.
  • Michaels MG; Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Preiksaitis J; Division of Pediatric Infectious Diseases, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Smets F; Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Swerdlow SH; Pediatric Gastroenterology and Hepatology, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
  • Trappe RU; Division of Hematopathology, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Wilkinson JD; Department of Hematology and Oncology, DIAKO Ev. Diakonie-Krankenhaus Bremen, Bremen, Germany and Department of Internal Medicine II: Hematology and Oncology, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Allen U; Department of Pediatrics, Vanderbilt School of Medicine, Nashville, Tennessee, USA.
  • Webber SA; Division of Infectious Diseases and the Transplant and Regenerative Medicine Center, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Dharnidharka VR; Department of Pediatrics, Vanderbilt School of Medicine, Nashville, Tennessee, USA.
Pediatr Transplant ; : e14350, 2022 Nov 11.
Article em En | MEDLINE | ID: mdl-36369745
ABSTRACT
The International Pediatric Transplant Association (IPTA) convened an expert consensus conference to assess current evidence and develop recommendations for various aspects of care relating to post-transplant lymphoproliferative disorder after solid organ transplantation in children. In this report from the Prevention Working Group, we reviewed the existing literature regarding immunoprophylaxis and chemoprophylaxis, and pre-emptive strategies. While the group made a strong recommendation for pre-emptive reduction of immunosuppression at the time of EBV DNAemia (low to moderate evidence), no recommendations for use could be made for any prophylactic strategy or alternate pre-emptive strategy, largely due to insufficient or conflicting evidence. Current gaps and future research priorities are highlighted.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article